Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions ...

ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on July 1, 2025 ...

Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and small molecule therapies for other ...

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to ...

Immunome, Inc. (the "Company") (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on July 1, 2025, the ...

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the ...

A market research company’s research shows that getting the gear to host a pool party costs less than it has in years.

Cameco Corporation (NYSE: CCJ) is one of the top 10 nuclear energy stocks to invest in for the next decade. On June 17, ...

CEO Frank Laukien has spent over $1.1 million so far this year buying stock in the open market. The stock is trading at about half of the 2024 highs, and it is clear the guy in charge thinks the ...

Cenovus Energy is boosting buybacks, redeeming preferreds, and raising its dividend despite short-term output impacts. See ...

With data as of July 2, 2025, we examine if Burford Capital Limited(BUR) is consistently building momentum based on AAII's A+ Investor Momentum and Value Scores and Grades.

Palantir Technologies (NASDAQ:PLTR) creates big data analytics software platforms that assist governments and companies in ...